Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT05806931

Public ClinicalTrials.gov record NCT05806931. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 3, 2026, 4:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Sequential Combined TAS-102 and Oxaliplatin Alternating With TAS-102 and Irinotecan (Sequential TASOXIRI) With Bevacizumab for Late-Line Metastatic Colorectal Cancer

Study identification

NCT ID: NCT05806931
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Rutgers, The State University of New Jersey; Other
Enrollment: 50 participants

Conditions and interventions

Conditions

Interventions

TAS-102, oxaliplatin, irinotecan with bevacizumab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 16, 2023
Primary completion: Apr 30, 2026
Completion: Apr 30, 2027
Last update posted: Mar 17, 2026

2023 – 2027

United States locations

U.S. sites: 9
U.S. states: 1
U.S. cities: 8

Facility	City	State	ZIP	Site status
Trinitas Hospital and Comprehensive Cancer Center	Elizabeth	New Jersey	07202	Recruiting
RWJBarnabas Health Jersey City Medical Center	Jersey City	New Jersey	07302	Recruiting
RWJBarnabas Health - Monmouth Medical Center Southern Campus	Lakewood	New Jersey	08701	Recruiting
Cooperman Barnabas Medical Center (Saint Barnabas Medical Center)	Livingston	New Jersey	07039	Recruiting
RWJBarnabas Health - Monmouth Medical Center	Long Branch	New Jersey	07740	Recruiting
Rutgers Cancer Institute of New Jersey	New Brunswick	New Jersey	08903	Recruiting
RWJBarnabas Health - Robert Wood Johnson University Hospital	New Brunswick	New Jersey	08903	Recruiting
RWJBarnabas Health - Robert Wood Johnson University Hospital	Somerset	New Jersey	08873	Recruiting
RWJBarnabas Health - Community Medical Center	Toms River	New Jersey	08755	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05806931, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 17, 2026 · Synced May 3, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05806931 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →